99 results
Page 2 of 5
8-K
EX-99.1
8t3rodxevh skwz5
17 Jun 22
Other Events
4:57pm
424B3
q1se05 0lj
1 Jun 22
Prospectus supplement
4:06pm
8-K
EX-10.1
p71dq iokp
20 May 22
Celularity Inc. Announces $30 Million Private Placement
4:06pm
8-K
EX-99.1
fc9zmftt0361vq5
20 May 22
Celularity Inc. Announces $30 Million Private Placement
4:06pm
424B3
ewdaez3kw7czcpp4f cz
16 May 22
Prospectus supplement
8:20pm
8-K
EX-99.1
ezzwsxe
16 May 22
Celularity Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:47pm
424B3
r71ghndueu3s6e
3 May 22
Prospectus supplement
4:06pm
POS AM
alz2xfdb2jxyyth hp
1 Apr 22
Prospectus update (post-effective amendment)
9:15pm
8-K
EX-99.1
rya dddsakawega
31 Mar 22
Celularity Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
4:06pm
424B3
t9ooiky ajuudf
16 Feb 22
Prospectus supplement
8:36am
8-K
EX-99.1
ma65ok lojv7
16 Feb 22
Other Events
8:31am
424B3
mocur
18 Jan 22
Prospectus supplement
4:11pm
8-K
EX-99.1
dmkwn9f3414a3et
18 Jan 22
Other Events
4:06pm
424B3
apfep
28 Dec 21
Prospectus supplement
4:05pm
8-K
EX-99.1
j27cnss2tkkw0b
28 Dec 21
Celularity Receives Fast Track Designation from U.S. FDA for its NK Cell Therapy CYNK-001 in Development for the Treatment of AML
4:01pm
424B3
0aidsngi 87g1m9d
12 Nov 21
Prospectus supplement
4:45pm